Year: 2017
Type: review
Abstract: Over the past few decades, research on Alzheimer's disease (AD) has focused on pathomechanisms linked to two of the major pathological hallmarks of extracellular deposition of beta-amyloid peptides and intra-neuronal formation of neurofibrils. Recently, a third disease component, the neuroinflammatory reaction mediated by cerebral innate immune cells, has entered the spotlight, prompted by findings from genetic, pre-clinical, and clinical studies. Various proteins that arise during neurodegeneration, including beta-amyloid, tau, heat shock proteins, and chromogranin, among others, act as danger-associated molecular patterns, that-upon engagement of pattern recognition receptors-induce inflammatory signaling pathways and ultimately lead to the production and release of immune mediators. These may have beneficial effects but ultimately compromise neuronal function and cause cell death. The current review, assembled by participants of the Chiclana Summer School on Neuroinflammation 2016, provides an overview of our current understanding of AD-related immune processes. We describe the principal cellular and molecular players in inflammation as they pertain to AD, examine modifying factors, and discuss potential future therapeutic targets.
Source: CNS Drugs
Authors: A. Ardura-Fabregat, E. W. G. M. Boddeke, A. Boza-Serrano, S. Brioschi, S. Castro-Gomez, K. Ceyzériat, C. Dansokho, T. Dierkes, G. Gelders, Michael T. Heneka, L. Hoeijmakers, A. Hoffmann, L. Iaccarino, S. Jahnert, K. Kuhbandner, G. Landreth, N. Lonnemann, P. A. Löschmann, R. M. McManus, A. Paulus, K. Reemst, J. M. Sanchez-Caro, A. Tiberi, A. Van der Perren, A. Vautheny, C. Venegas, A. Webers, P. Weydt, T. S. Wijasa, X. Xiang, Y. Yang
Institutions: University of Freiburg, University Medical Center Groningen, University of Groningen, Lund University, University Medical Center Freiburg, University of Bonn, Université Paris-Sud, Centre National de la Recherche Scientifique, Commissariat à l'Énergie Atomique et aux Énergies Alternatives, Institut d'Imagerie Biomédicale, CEA Paris-Saclay - Etablissement de Fontenay-aux-roses, Direction de la Recherche Fondamentale, Laboratoire des Maladies Neurodégénératives, Molecular Imaging Research Center, Institut de biologie François Jacob, German Center for Neurodegenerative Diseases, University Hospital Bonn, KU Leuven, University of Amsterdam, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsklinikum Erlangen, Vita-Salute San Raffaele University, IRCCS Ospedale San Raffaele, Indiana University School of Medicine, Technische Universität Braunschweig, Pfizer (Germany), Scuola Normale Superiore, Ludwig-Maximilians-Universität München
Language: English
Subfield: Neurology
Field: Neuroscience
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $5,090
OpenAlex ID: W2777733505
